CoChat
Sign Up
Cited by 62

The DOI matches its Crossref record; 11 of the 11 references it cites were found in a registry or an index.

Genetic variation in APOE cluster region and Alzheimer's disease risk

Cervantes, Sebastián, Samaranch, Lluís, Vidal-Taboada, José Manuel, Lamet, Isabel, Bullido, María Jesús, Frank-García, Ana, Coria, Francisco, Lleó, Albert, Clarimón, Jordi, Lorenzo, Elena, Alonso, Elena, Sánchez-Juan, Pascual, Rodríguez-Rodríguez, Eloy, Combarros, Onofre, Rosich, Marcel, Vilella, Elisabet, Pastor, Pau·2011·Neurobiology of Aging
DOI 10.1016/j.neurobiolaging.2011.05.023
Open this paper in CoChat — free account

Abstract

We report the fine mapping/sequencing results of promoter and regulatory regions of APOE cluster genes (APOE, APOC1, APOC4, APOC2, and TOMM40) in Alzheimer's disease (AD) risk as well as in the progression from mild cognitive impairment (MCI) to AD. Long-range sequencing in 29 MCI subjects who progressed to dementia revealed 7 novel variants. Two potentially relevant novel variants and 34 single nucleotide polymorphisms (SNPs) were genotyped in a large sample of AD, MCI, and control subjects (n = 1453). Globally, very little association signal was observed in our sample in the absence of APOE ε4. Rs5158 (APOC4 intron 1) and rs10413089 (3' to APOC2) showed a trend toward an increase in AD risk independently from APOE ε4 associated risk though it did not survive multiple test correction (uncorrected p = 0.0099 and 0.01, respectively). Interestingly, rs10413089 showed a similar effect in an independent series. The analysis of the discovery sample showed an association of TOMM40 single nucleotide polymorphisms with progression from MCI stage to AD (rs59007384 and rs11556510), as well as with a shorter time to progression from MCI status to AD (rs10119), though these results could not be replicated in independent series. Further studies are needed to investigate the role of APOE cluster variants in AD risk.

Overview

Integrity signals

Registry

Crossref · 10.1016/j.neurobiolaging.2011.05.023

Cites

11 of 11 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Research works printed but not linked: 50

  1. Abhary, 2010, Sequence variation in DDAH1 and DDAH2 genes is strongly and additively associated with serum ADMA concentrations in individuals with type 2 diabetes, PLoS One, 5, e9462, 10.1371/journal.pone.0009462 · DOI
  2. Abraham, 2008, A genome-wide association study for late-onset Alzheimer's disease using DNA pooling, BMC Med. Genomics, 1, 44, 10.1186/1755-8794-1-44 · DOI · Paper page
  3. Allan, 1995, Identification and characterization of a new human gene (APOC4) in the apolipoprotein E, C–I, and C–II gene locus, Genomics, 28, 291, 10.1006/geno.1995.1144 · DOI
  4. 2010, 2010 Alzheimer's disease facts and figures, Alzheimers Dement, 6, 158, 10.1016/j.jalz.2010.01.009 · DOI
  5. Ariza, 2010, Additive effects of LPL, APOA5 and APOE variant combinations on triglyceride levels and hypertriglyceridemia: results of the Icaria genetic sub-study, BMC Med. Genet, 11, 66, 10.1186/1471-2350-11-66 · DOI
  6. Barrett, 2005, Haploview: analysis and visualization of LD and haplotype maps, Bioinformatics, 21, 263, 10.1093/bioinformatics/bth457 · DOI
  7. Bekris, 2008, Multiple SNPs within and surrounding the apolipoprotein E gene influence cerebrospinal fluid apolipoprotein E protein levels, J. Alzheimers Dis, 13, 255, 10.3233/JAD-2008-13303 · DOI · Paper page
  8. Belbin, 2007, Regulatory region single nucleotide polymorphisms of the apolipoprotein E gene and the rate of cognitive decline in Alzheimer's disease, Hum. Mol. Genet, 16, 2199, 10.1093/hmg/ddm171 · DOI
  9. Bertram, 2008, Genome-wide association analysis reveals putative Alzheimer's disease susceptibility loci in addition to APOE, Am. J. Hum. Genet, 83, 623, 10.1016/j.ajhg.2008.10.008 · DOI · Paper page
  10. Blom, 2008, Does APOE explain the linkage of Alzheimer's disease to chromosome 19q13?, Am. J. Med. Genet. B Neuropsychiatr. Genet, 147B, 778, 10.1002/ajmg.b.30681 · DOI
  11. Bullido, 1998, A polymorphism in the regulatory region of APOE associated with risk for Alzheimer's dementia, Nat. Genet, 18, 69, 10.1038/ng0198-69 · DOI
  12. Bullido, 2000, Apolipoprotein E gene promoter polymorphisms in Alzheimer's disease, Microsc. Res. Tech, 50, 261, 10.1002/1097-0029(20000815)50:4<261::AID-JEMT2>3.0.CO;2-B · DOI
  13. Cartharius, 2005, MatInspector and beyond: promoter analysis based on transcription factor binding sites, Bioinformatics, 21, 2933, 10.1093/bioinformatics/bti473 · DOI
  14. Chartier-Harlin, 1994, Apolipoprotein E, epsilon 4 allele as a major risk factor for sporadic early and late-onset forms of Alzheimer's disease: analysis of the 19q132 chromosomal region, Hum. Mol. Genet, 3, 569, 10.1093/hmg/3.4.569 · DOI
  15. Corder, 1993, Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families, Science, 261, 921, 10.1126/science.8346443 · DOI · Paper page
  16. Coria, 1995, Apolipoprotein E allelic variants predict dementia in elderly patients with memory impairment, Eur. J. Neurol, 2, 191, 10.1111/j.1468-1331.1995.tb00116.x · DOI
  17. Crean, 2011, Apolipoprotein E ε4 prevalence in Alzheimer's disease patients varies across global populations: a systematic literature review and meta-analysis, Dement. Geriatr. Cogn. Disord, 31, 20, 10.1159/000321984 · DOI · Paper page
  18. Cruchaga, 2009, Cortical atrophy and language network reorganization associated with a novel progranulin mutation, Cereb. Cortex, 19, 1751, 10.1093/cercor/bhn202 · DOI
  19. Del Greco, 2011, Genome-wide association analysis and fine mapping of NT-proBNP level provide novel insight into the role of the MTHFR-CLCN6-NPPA-NPPB gene cluster, Hum. Mol. Genet, 20, 1660, 10.1093/hmg/ddr035 · DOI
  20. Desmet, 2009, Human Splicing Finder: an online bioinformatics tool to predict splicing signals, Nucleic Acids Res, 37, e67, 10.1093/nar/gkp215 · DOI
  21. Drigalenko, 1998, Interaction of the apolipoprotein E and CI loci in predisposing to late-onset Alzheimer's disease, Neurology, 51, 131, 10.1212/WNL.51.1.131 · DOI
  22. Ezquerra, 2003, A novel mutation in the PSEN2 gene (T430M) associated with variable expression in a family with early-onset Alzheimer disease, Arch. Neurol, 60, 1149, 10.1001/archneur.60.8.1149 · DOI
  23. Gabriel, 2003, Tom40, the import channel of the mitochondrial outer membrane, plays an active role in sorting imported proteins, EMBO J, 22, 2380, 10.1093/emboj/cdg229 · DOI
  24. Gatz, 2006, Role of genes and environments for explaining Alzheimer disease, Arch. Gen. Psychiatry, 63, 168, 10.1001/archpsyc.63.2.168 · DOI · Paper page
  25. Goate, 1991, Segregation of a missense mutation in the amyloid precursor protein gene with familial Alzheimer's disease, Nature, 349, 704, 10.1038/349704a0 · DOI · Paper page
  26. Hong, 2010, Genome-wide pathway analysis implicates intracellular transmembrane protein transport in Alzheimer disease, J. Hum. Genet, 55, 707, 10.1038/jhg.2010.92 · DOI
  27. Lambert, 2002, Contribution of APOE promoter polymorphisms to Alzheimer's disease risk, Neurology, 59, 59, 10.1212/WNL.59.1.59 · DOI
  28. Lambert, 2009, Genome-wide association study identifies variants at CLU and CR1 associated with Alzheimer's disease, Nat. Genet, 41, 1094, 10.1038/ng.439 · DOI · Paper page
  29. Lambert, 1997, Distortion of allelic expression of apolipoprotein E in Alzheimer's disease, Hum. Mol. Genet, 6, 2151, 10.1093/hmg/6.12.2151 · DOI
  30. Li, 2008, Candidate single-nucleotide polymorphisms from a genomewide association study of Alzheimer disease, Arch. Neurol, 65, 45, 10.1001/archneurol.2007.3 · DOI · Paper page
  31. Lleó, 2001, A novel presenilin 2 gene mutation (D439A) in a patient with early-onset Alzheimer's disease, Neurology, 57, 1926, 10.1212/WNL.57.10.1926 · DOI
  32. Lutz, 2010, Genetic variation at a single locus and age of onset for Alzheimer's disease, Alzheimers Dement, 6, 125, 10.1016/j.jalz.2010.01.011 · DOI
  33. Manso, 2010, Variants of the Matrix Metalloproteinase-2 but not the Matrix Metalloproteinase-9 genes significantly influence functional outcome after stroke, BMC Med. Genet, 11, 40, 10.1186/1471-2350-11-40 · DOI
  34. Nyholt, 2004, A simple correction for multiple testing for single-nucleotide polymorphisms in linkage disequilibrium with each other, Am. J. Hum. Genet, 74, 765, 10.1086/383251 · DOI · Paper page
  35. Orozco, 2009, Combined effects of three independent SNPs greatly increase the risk estimate for RA at 6q23, Hum. Mol. Genet, 18, 2693, 10.1093/hmg/ddp193 · DOI
  36. Petersen, 1999, Mild Cognitive impairment: clinical characterization and outcome, Arch. Neurol, 56, 303, 10.1001/archneur.56.3.303 · DOI · Paper page
  37. Purcell, 2007, PLINK: a tool set for whole-genome association and population-based linkage analyses, Am. J. Hum. Genet, 81, 559, 10.1086/519795 · DOI · Paper page
  38. Quandt, 1995, MatInd and MatInspector: new fast and versatile tools for detection of consensus matches in nucleotide sequence data, Nucleic Acids Res, 23, 4878, 10.1093/nar/23.23.4878 · DOI
  39. Roses, 2010, A TOMM40 variable-length polymorphism predicts the age of late-onset Alzheimer's disease, Pharmacogenomics J, 10, 375, 10.1038/tpj.2009.69 · DOI
  40. Samaranch, 2010, The effect of MAPT H1 and APOE ε4 on transition from mild cognitive impairment to dementia, J. Alzheimers Dis, 22, 1065, 10.3233/JAD-2010-101011 · DOI
  41. Schulze, 2009, Two variants in Ankyrin 3 (ANK3) are independent genetic risk factors for bipolar disorder, Mol. Psychiatry, 14, 487, 10.1038/mp.2008.134 · DOI
  42. Seshadri, 2010, Genome-wide analysis of genetic loci associated with Alzheimer disease, JAMA, 303, 1832, 10.1001/jama.2010.574 · DOI · Paper page
  43. Sherrington, 1995, Cloning of a gene bearing missense mutations in early-onset familial Alzheimer's disease, Nature, 375, 754, 10.1038/375754a0 · DOI · Paper page
  44. Shin, 2010, Association between colony-stimulating factor 1 receptor gene polymorphisms and asthma risk, Hum. Genet, 128, 293, 10.1007/s00439-010-0850-3 · DOI
  45. Strittmatter, 1993, Apolipoprotein E: high-avidity binding to beta-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease, Proc. Natl. Acad. Sci. U. S. A., 90, 1977, 10.1073/pnas.90.5.1977 · DOI · Paper page
  46. Sun, 2005, The APOC3 SstI polymorphism is weakly associated with sporadic Alzheimer's disease in a Chinese population, Neurosci. Lett, 380, 219, 10.1016/j.neulet.2005.01.038 · DOI
  47. Takei, 2009, Genetic association study on in and around the APOE in late-onset Alzheimer disease in Japanese, Genomics, 93, 441, 10.1016/j.ygeno.2009.01.003 · DOI
  48. Wei, 1985, The structure of the human apolipoprotein C-II gene, Biol. Chem, 260, 15211, 10.1016/S0021-9258(18)95724-8 · DOI
  49. Xin, 2010, Apolipoprotein E promoter polymorphisms and risk of Alzheimer's disease: evidence from meta-analysis, J. Alzheimers Dis, 19, 1283, 10.3233/JAD-2010-1329 · DOI
  50. Yu, 2007, Comprehensive analysis of APOE and selected proximate markers for late-onset Alzheimer's disease: patterns of linkage disequilibrium and disease/marker association, Genomics, 89, 655, 10.1016/j.ygeno.2007.02.002 · DOI

Cited by

Sorted by citations

See all 62

Metadata

Authors
Cervantes, S., Samaranch, L., Vidal-Taboada, J. M., Lamet, I., Bullido, M. J., Frank-García, A., Coria, F., Lleó, A., Clarimón, J., Lorenzo, E., Alonso, E., Sánchez-Juan, P., Rodríguez-Rodríguez, E., Combarros, O., Rosich, M., Vilella, E., & Pastor, P.
Venue
Neurobiology of Aging
Publisher
Elsevier BV
Published
2011-11
Volume
32
Issue
11
Pages
2107.e7-2107.e17
ISSN
0197-4580
DOI
10.1016/j.neurobiolaging.2011.05.023
Cited by
62
References
11
Language
en
Licence
www.elsevier.com/tdm/userlicense/1.0/ (tdm)
Funders
Department of Health of the Government of Navarra

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review